156 related articles for article (PubMed ID: 28525371)
1. Arsenic trioxide and angiotensin II have inhibitory effects on HERG protein expression: Evidence for the role of PML SUMOylation.
Liu Y; Li D; Nie D; Liu SK; Qiu F; Liu MT; Li YY; Wang JX; Liu YX; Dong CJ; Wu D; Tian W; Yang J; Mu W; Li JT; Zhao D; Wang XF; Chu WF; Yang BF
Oncotarget; 2017 Jul; 8(28):45447-45458. PubMed ID: 28525371
[TBL] [Abstract][Full Text] [Related]
2. Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.
Liu Y; Zhao D; Qiu F; Zhang LL; Liu SK; Li YY; Liu MT; Wu D; Wang JX; Ding XQ; Liu YX; Dong CJ; Shao XQ; Yang BF; Chu WF
Mol Ther; 2017 Mar; 25(3):666-678. PubMed ID: 28143738
[TBL] [Abstract][Full Text] [Related]
3. Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts.
Xu WX; Liu SZ; Wu D; Qiao GF; Yan J
Cell Physiol Biochem; 2015; 37(4):1581-91. PubMed ID: 26517826
[TBL] [Abstract][Full Text] [Related]
4. Role of PML SUMOylation in arsenic trioxide-induced fibrosis in HSCs.
Dai J; Hu Y; Niu Q; Song G; Wang H; Li S
Life Sci; 2020 Jun; 251():117607. PubMed ID: 32240679
[TBL] [Abstract][Full Text] [Related]
5. Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome.
Chu W; Li C; Qu X; Zhao D; Wang X; Yu X; Cai F; Liang H; Zhang Y; Zhao X; Li B; Qiao G; Dong D; Lu Y; Du Z; Yang B
Cardiovasc Res; 2012 Oct; 96(1):90-8. PubMed ID: 22853924
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1-PML SUMOylation-peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) form a positive feedback loop to regulate cardiac fibrosis.
Wu D; Huang D; Li LL; Ni P; Li XX; Wang B; Han YN; Shao XQ; Zhao D; Chu WF; Li BY
J Cell Physiol; 2019 May; 234(5):6263-6273. PubMed ID: 30246389
[TBL] [Abstract][Full Text] [Related]
7. PCGF2 negatively regulates arsenic trioxide-induced PML-RARA protein degradation via UBE2I inhibition in NB4 cells.
Jo S; Lee YL; Kim S; Lee H; Chung H
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1499-509. PubMed ID: 27030546
[TBL] [Abstract][Full Text] [Related]
8. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide-induced hERG K(+) channel deficiency can be rescued by matrine and oxymatrine through up-regulating transcription factor Sp1 expression.
Zhang Y; Dong Z; Jin L; Zhang K; Zhao X; Fu J; Gong Y; Sun M; Yang B; Li B
Biochem Pharmacol; 2013 Jan; 85(1):59-68. PubMed ID: 23103450
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epicatechin rescues the As
Dong Z; Shi Y; Feng L; Shen Z; Fang L; Zheng S; Hai X; Li B
J Biochem Mol Toxicol; 2017 Nov; 31(11):. PubMed ID: 28768059
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of ether-a-go-go-related gene potassium channel protein through sustained stimulation of AT1 receptor by angiotensin II.
Cai Y; Wang Y; Xu J; Zuo X; Xu Y
Biochem Biophys Res Commun; 2014 Sep; 452(3):852-7. PubMed ID: 25218469
[TBL] [Abstract][Full Text] [Related]
12. SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.
Cao X; Clavijo C; Li X; Lin HH; Chen Y; Shih HM; Ann DK
Mol Cancer Ther; 2008 Apr; 7(4):923-34. PubMed ID: 18413806
[TBL] [Abstract][Full Text] [Related]
13. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
[TBL] [Abstract][Full Text] [Related]
14. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
Hirano S; Udagawa O
Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
[TBL] [Abstract][Full Text] [Related]
15. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.
Jeanne M; Lallemand-Breitenbach V; Ferhi O; Koken M; Le Bras M; Duffort S; Peres L; Berthier C; Soilihi H; Raught B; de Thé H
Cancer Cell; 2010 Jul; 18(1):88-98. PubMed ID: 20609355
[TBL] [Abstract][Full Text] [Related]
16. Differential Regulation of Human Ether-à-Go-Go-Related Gene (hERG) Current and Expression by Activation of Protein Kinase C.
Sutherland-Deveen ME; Wang T; Lamothe SM; Tschirhart JN; Guo J; Li W; Yang T; Du Y; Zhang S
Mol Pharmacol; 2019 Jul; 96(1):1-12. PubMed ID: 31015282
[TBL] [Abstract][Full Text] [Related]
17. RING tetramerization is required for nuclear body biogenesis and PML sumoylation.
Wang P; Benhenda S; Wu H; Lallemand-Breitenbach V; Zhen T; Jollivet F; Peres L; Li Y; Chen SJ; Chen Z; de Thé H; Meng G
Nat Commun; 2018 Mar; 9(1):1277. PubMed ID: 29599493
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.
Zhang XW; Yan XJ; Zhou ZR; Yang FF; Wu ZY; Sun HB; Liang WX; Song AX; Lallemand-Breitenbach V; Jeanne M; Zhang QY; Yang HY; Huang QH; Zhou GB; Tong JH; Zhang Y; Wu JH; Hu HY; de Thé H; Chen SJ; Chen Z
Science; 2010 Apr; 328(5975):240-3. PubMed ID: 20378816
[TBL] [Abstract][Full Text] [Related]
19. Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma.
Zhang X; Yang XR; Sun C; Hu B; Sun YF; Huang XW; Wang Z; He YF; Zeng HY; Qiu SJ; Cao Y; Fan J; Zhou J
Cancer Lett; 2015 Sep; 366(1):112-22. PubMed ID: 26118777
[TBL] [Abstract][Full Text] [Related]
20. Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation.
Wang QQ; Zhou XY; Zhang YF; Bu N; Zhou J; Cao FL; Naranmandura H
Oncotarget; 2015 Sep; 6(28):25646-59. PubMed ID: 26213848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
